Cargando…
X-ray and cryo-EM structures of inhibitor-bound cytochrome bc (1) complexes for structure-based drug discovery
Cytochrome bc (1), a dimeric multi-subunit electron-transport protein embedded in the inner mitochondrial membrane, is a major drug target for the treatment and prevention of malaria and toxoplasmosis. Structural studies of cytochrome bc (1) from mammalian homologues co-crystallized with lead compou...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947725/ https://www.ncbi.nlm.nih.gov/pubmed/29765610 http://dx.doi.org/10.1107/S2052252518001616 |
_version_ | 1783322427777875968 |
---|---|
author | Amporndanai, Kangsa Johnson, Rachel M. O’Neill, Paul M. Fishwick, Colin W. G. Jamson, Alexander H. Rawson, Shaun Muench, Stephen P. Hasnain, S. Samar Antonyuk, Svetlana V. |
author_facet | Amporndanai, Kangsa Johnson, Rachel M. O’Neill, Paul M. Fishwick, Colin W. G. Jamson, Alexander H. Rawson, Shaun Muench, Stephen P. Hasnain, S. Samar Antonyuk, Svetlana V. |
author_sort | Amporndanai, Kangsa |
collection | PubMed |
description | Cytochrome bc (1), a dimeric multi-subunit electron-transport protein embedded in the inner mitochondrial membrane, is a major drug target for the treatment and prevention of malaria and toxoplasmosis. Structural studies of cytochrome bc (1) from mammalian homologues co-crystallized with lead compounds have underpinned structure-based drug design to develop compounds with higher potency and selectivity. However, owing to the limited amount of cytochrome bc (1) that may be available from parasites, all efforts have been focused on homologous cytochrome bc (1) complexes from mammalian species, which has resulted in the failure of some drug candidates owing to toxicity in the host. Crystallographic studies of the native parasite proteins are not feasible owing to limited availability of the proteins. Here, it is demonstrated that cytochrome bc (1) is highly amenable to single-particle cryo-EM (which uses significantly less protein) by solving the apo and two inhibitor-bound structures to ∼4.1 Å resolution, revealing clear inhibitor density at the binding site. Therefore, cryo-EM is proposed as a viable alternative method for structure-based drug discovery using both host and parasite enzymes. |
format | Online Article Text |
id | pubmed-5947725 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-59477252018-05-15 X-ray and cryo-EM structures of inhibitor-bound cytochrome bc (1) complexes for structure-based drug discovery Amporndanai, Kangsa Johnson, Rachel M. O’Neill, Paul M. Fishwick, Colin W. G. Jamson, Alexander H. Rawson, Shaun Muench, Stephen P. Hasnain, S. Samar Antonyuk, Svetlana V. IUCrJ Research Papers Cytochrome bc (1), a dimeric multi-subunit electron-transport protein embedded in the inner mitochondrial membrane, is a major drug target for the treatment and prevention of malaria and toxoplasmosis. Structural studies of cytochrome bc (1) from mammalian homologues co-crystallized with lead compounds have underpinned structure-based drug design to develop compounds with higher potency and selectivity. However, owing to the limited amount of cytochrome bc (1) that may be available from parasites, all efforts have been focused on homologous cytochrome bc (1) complexes from mammalian species, which has resulted in the failure of some drug candidates owing to toxicity in the host. Crystallographic studies of the native parasite proteins are not feasible owing to limited availability of the proteins. Here, it is demonstrated that cytochrome bc (1) is highly amenable to single-particle cryo-EM (which uses significantly less protein) by solving the apo and two inhibitor-bound structures to ∼4.1 Å resolution, revealing clear inhibitor density at the binding site. Therefore, cryo-EM is proposed as a viable alternative method for structure-based drug discovery using both host and parasite enzymes. International Union of Crystallography 2018-02-20 /pmc/articles/PMC5947725/ /pubmed/29765610 http://dx.doi.org/10.1107/S2052252518001616 Text en © Kangsa Amporndanai et al. 2018 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.http://creativecommons.org/licenses/by/2.0/uk/ |
spellingShingle | Research Papers Amporndanai, Kangsa Johnson, Rachel M. O’Neill, Paul M. Fishwick, Colin W. G. Jamson, Alexander H. Rawson, Shaun Muench, Stephen P. Hasnain, S. Samar Antonyuk, Svetlana V. X-ray and cryo-EM structures of inhibitor-bound cytochrome bc (1) complexes for structure-based drug discovery |
title | X-ray and cryo-EM structures of inhibitor-bound cytochrome bc
(1) complexes for structure-based drug discovery |
title_full | X-ray and cryo-EM structures of inhibitor-bound cytochrome bc
(1) complexes for structure-based drug discovery |
title_fullStr | X-ray and cryo-EM structures of inhibitor-bound cytochrome bc
(1) complexes for structure-based drug discovery |
title_full_unstemmed | X-ray and cryo-EM structures of inhibitor-bound cytochrome bc
(1) complexes for structure-based drug discovery |
title_short | X-ray and cryo-EM structures of inhibitor-bound cytochrome bc
(1) complexes for structure-based drug discovery |
title_sort | x-ray and cryo-em structures of inhibitor-bound cytochrome bc
(1) complexes for structure-based drug discovery |
topic | Research Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947725/ https://www.ncbi.nlm.nih.gov/pubmed/29765610 http://dx.doi.org/10.1107/S2052252518001616 |
work_keys_str_mv | AT amporndanaikangsa xrayandcryoemstructuresofinhibitorboundcytochromebc1complexesforstructurebaseddrugdiscovery AT johnsonrachelm xrayandcryoemstructuresofinhibitorboundcytochromebc1complexesforstructurebaseddrugdiscovery AT oneillpaulm xrayandcryoemstructuresofinhibitorboundcytochromebc1complexesforstructurebaseddrugdiscovery AT fishwickcolinwg xrayandcryoemstructuresofinhibitorboundcytochromebc1complexesforstructurebaseddrugdiscovery AT jamsonalexanderh xrayandcryoemstructuresofinhibitorboundcytochromebc1complexesforstructurebaseddrugdiscovery AT rawsonshaun xrayandcryoemstructuresofinhibitorboundcytochromebc1complexesforstructurebaseddrugdiscovery AT muenchstephenp xrayandcryoemstructuresofinhibitorboundcytochromebc1complexesforstructurebaseddrugdiscovery AT hasnainssamar xrayandcryoemstructuresofinhibitorboundcytochromebc1complexesforstructurebaseddrugdiscovery AT antonyuksvetlanav xrayandcryoemstructuresofinhibitorboundcytochromebc1complexesforstructurebaseddrugdiscovery |